Remove 2002 Remove Doctors Remove FDA Remove Fraud
article thumbnail

CPAP MDL Overinflates Plaintiffs’ Claims

Drug & Device Law

2002). “[I]t is not the role of a federal court to expand state law in ways not foreshadowed by state precedent.” Taking the good doctor first, In re Philips Recalled CPAP, Bi-Level Pap, & Mechanical Ventilator Products Litigation , 2023 WL 7019667 (Sp. Ford Motor Co. , 3d 661, 680 (3d Cir. City of Philadelphia v. Beretta U.S.A.

Fraud 52
article thumbnail

California Appellate Court Reaffirms Federal Preemption, Learned Intermediary Doctrine in Amiodarone Cases

Drug & Device Law

3, 2002) (to be published), the California Court of Appeal held that federal law preempts state law failure-to-warn claims alleging that branded and generic drug manufacturers did not ensure that patients received FDA-approved Medication Guides for amiodarone, a heart medicine. In Amiodarone Cases , No. A161023, 2022 WL 16646728 (Cal.

FDA 52